Novo Nordisk sues GLP-1 rival Eli Lilly over claims of false advertising

Novo Nordisk filed a lawsuit claiming Eli Lilly ran “false and materially misleading” advertisements that ignore recent data. According to Lilly, though, its message is “truthful” and “grounded in the most direct scientific evidence available.”Read More